Description of Collaborative Activity: |
The DxIPT was established by the USG Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Executive Committee. The DxIPT will advise leadership on investments in human health diagnostics, medical countermeasures to improve the response to chemical, biological, radiological, and nuclear threats, pandemic influenza, and emerging infectious diseases. Members include Federal employees or contractors to the Federal Government with diverse expertise in diagnostics. In 2012, DxIPT was charged with two tasks: 1) to reevaluate the feasibility of anthrax diagnostics for asymptomatic infections and 2) to develop Quantitative Technological Readiness Levels (Q-TRLs) for diagnostics to represent milestones and activities for the product development lifecycle from discovery through post-approval. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
